{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:04:07Z","timestamp":1789679047579,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011301","name":"Children\u2019s Hospital of Wisconsin Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaci.2020.07.021","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T21:30:46Z","timestamp":1596231046000},"page":"704-712.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency"],"prefix":"10.1016","volume":"147","author":[{"given":"James W.","family":"Verbsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Hintermeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pippa M.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Barbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagarjun","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlyne D.","family":"Cool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Sosa-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj","family":"Baruah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Hammelev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Busalacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Rymaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Woodliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Bausch-Jurken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Routes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.07.021_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.07.021_bib2","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.07.021_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/pai.12890","article-title":"Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T cells","volume":"29","author":"Deya-Martinez","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10875-016-0320-3","article-title":"X-linked inhibitor of apoptosis complicated by granulomatous lymphocytic interstitial lung disease (GLILD) and granulomatous hepatitis","volume":"36","author":"Steele","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib5","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jaci.2020.07.021_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10875-015-0224-7","article-title":"Spectrum of phenotypes associated with mutations in LRBA","volume":"36","author":"Alkhairy","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib7","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.jaci.2018.02.007","article-title":"Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency","volume":"141","author":"Lawless","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10875-014-0121-5","article-title":"Identification of patients with RAG mutations previously diagnosed with common variable immunodeficiency disorders","volume":"35","author":"Buchbinder","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2015.06.002","article-title":"Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome","volume":"137","author":"Lindsley","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib10","article-title":"Common variable immunodeficiency with genetic defects identified by whole exome sequencing","volume":"2018","author":"Li","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jaci.2020.07.021_bib11","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib12","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.humpath.2015.05.011","article-title":"Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency--histologic and immunohistochemical analyses of 16 cases","volume":"46","author":"Rao","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaci.2020.07.021_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-012-9755-3","article-title":"Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID)","volume":"33","author":"Chase","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.rmed.2008.12.015","article-title":"High resolution computed tomography and pulmonary function in common variable immunodeficiency","volume":"103","author":"Gregersen","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2020.07.021_bib15","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.07.021_bib16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.200709-1365OC","article-title":"Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis","volume":"178","author":"Akira","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.07.021_bib17","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201710-1981ST","article-title":"Recommendations for a standardized pulmonary function report. an official American Thoracic Society Technical Statement","volume":"196","author":"Culver","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.07.021_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.05.00034505","article-title":"General considerations for lung function testing","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.07.021_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/GIM.0b013e3182088158","article-title":"Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease","volume":"13","author":"Worthey","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.jaci.2020.07.021_bib21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1513\/AnnalsATS.201511-728OC","article-title":"Clinical\u00a0predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease","volume":"13","author":"Mannina","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaci.2020.07.021_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028150","article-title":"Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies","volume":"9","author":"Thomas","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaci.2020.07.021_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.07.021_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s10875-010-9424-3","article-title":"B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease","volume":"30","author":"Mouillot","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib25","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/ccr3.1257","article-title":"Fatal CTLA-4 heterozygosity with autoimmunity and recurrent infections: a de novo mutation","volume":"5","author":"Moraes-Fontes","year":"2017","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.jaci.2020.07.021_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s10875-014-0068-6","article-title":"CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters","volume":"34","author":"Maarschalk-Ellerbroek","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib28","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3899\/jrheum.171362","article-title":"Performance of forced vital capacity and lung diffusion cutpoints for associated radiographic interstitial lung disease in systemic sclerosis","volume":"45","author":"Showalter","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2020.07.021_bib29","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/art.39405","article-title":"Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease","volume":"67","author":"Suliman","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2020.07.021_bib30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaip.2014.09.019","article-title":"Serum IL-12 and soluble IL-2 receptor levels as possible biomarkers of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency: a case report","volume":"3","author":"Vitale","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.07.021_bib32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ajmg.a.30722","article-title":"Immune abnormalities are a frequent manifestation of Kabuki syndrome","volume":"135","author":"Hoffman","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jaci.2020.07.021_bib33","first-page":"15","article-title":"An 18-year-old woman with Kabuki syndrome, immunoglobulin deficiency and granulomatous lymphocytic interstitial lung disease","volume":"76","author":"De Dios","year":"2012","journal-title":"Conn Med"},{"key":"10.1016\/j.jaci.2020.07.021_bib34","article-title":"Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals","author":"Margot","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.jaci.2020.07.021_bib35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0091-6749(96)70108-2","article-title":"Hypersensitivity pneumonitis in a patient with hypogammaglobulinemia","volume":"98","author":"Schkade","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clim.2009.10.002","article-title":"Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID)","volume":"134","author":"Park","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","article-title":"Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency","volume":"114","author":"Bates","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib38","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0012-2017","article-title":"Differential diagnosis of granulomatous lung disease: clues and pitfalls: number 4 in the series \u201cPathology for the Clinician\u201d edited by Peter Dorfmuller and Alberto Cavazza","volume":"26","author":"Ohshimo","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaci.2020.07.021_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-215624","article-title":"Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency","volume":"2016","author":"Pathria","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaci.2020.07.021_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fped.2019.00105","article-title":"Treatment-responsive granulomatous-lymphocytic interstitial lung disease in\u00a0a\u00a0pediatric case of common variable immunodeficiency","volume":"7","author":"Tillman","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2020.07.021_bib41","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/cei.12856","article-title":"FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID)","volume":"187","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib42","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jaip.2018.10.041","article-title":"Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous\u00a0and lymphocytic interstitial lung disease in patients with common\u00a0variable immunodeficiency","volume":"7","author":"Cereser","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.07.021_bib43","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaci.2006.01.034","article-title":"Etanercept treatment of cutaneous granulomas in common variable immunodeficiency","volume":"117","author":"Lin","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib44","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s10875-014-0079-3","article-title":"Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency","volume":"34","author":"Franxman","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10875-012-9778-9","article-title":"Granulomatous disease in CVID: retrospective analysis of clinical characteristics\u00a0and treatment efficacy in a cohort of 59 patients","volume":"33","author":"Boursiquot","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.021_bib46","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1002\/ppul.23757","article-title":"Efficacy of mycophenolate on lung disease and autoimmunity in children with immunodeficiency","volume":"52","author":"Bucciol","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jaci.2020.07.021_bib47","first-page":"20","article-title":"Granulomatous lymphocytic interstitial lung disease in infancy","volume":"21","author":"Adeleye","year":"2014","journal-title":"Can Respir J"},{"key":"10.1016\/j.jaci.2020.07.021_bib48","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.2169\/internalmedicine.7757-16","article-title":"Intravenous immunoglobulin monotherapy for granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"56","author":"Hasegawa","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.jaci.2020.07.021_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122728","article-title":"BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency","volume":"4","author":"Maglione","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2020.07.021_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12948-019-0113-3","article-title":"Immunosuppressive therapy with rituximab in common variable immunodeficiency","volume":"17","author":"Pecoraro","year":"2019","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jaci.2020.07.021_bib51","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaip.2017.01.021","article-title":"British Lung Foundation\/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders","volume":"5","author":"Hurst","year":"2017","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920310691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920310691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:28:43Z","timestamp":1789676923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920310691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0091674920310691"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.07.021","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}